title: The Case | Subcutaneous abdominal calcified nodules and severe hyperphosphatemia.
authors.affiliation: Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
authors.forename: Benjamin
authors.initials: B
authors.lastname: Seront
authors.affiliation: Division of Dermatology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
authors.forename: Liliane
authors.initials: L
authors.lastname: Marot
authors.affiliation: Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
authors.forename: Nathalie
authors.initials: N
authors.lastname: Demoulin
authors.affiliation: Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.
authors.forename: Michel
authors.initials: M
authors.lastname: Jadoul
authors.affiliation: Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium. Electronic address: johann.morelle@uclouvain.be.
authors.forename: Johann
authors.initials: J
authors.lastname: Morelle
mesh_terms: D000005:Abdomen; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects*; D001706:Biopsy; D002114:Calcinosis / Q000139:chemically induced* / Q000175:diagnosis; D002614:Chelating Agents / Q000627:therapeutic use; D057915:Drug Substitution; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D017762:Nadroparin / Q000009:adverse effects*; D012307:Risk Factors; D000069603:Sevelamer / Q000627:therapeutic use; D012720:Severity of Illness Index; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D012871:Skin Diseases / Q000139:chemically induced* / Q000175:diagnosis; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D002614:Chelating Agents; D017984:Enoxaparin; D017762:Nadroparin; D000069603:Sevelamer